Home » Topics » Diagnostics, BioWorld Science

Diagnostics, BioWorld Science
RSS

FDA approves Detectnet

Sep. 9, 2020

FluoGuide obtains Danish clearance for phase I/II trial of FG-001 to guide glioma surgery

Sep. 7, 2020

First-in-human data presented for [68Ga]P15-041 radiotracer

Aug. 13, 2020

HTA presents new prostate cancer diagnosis probe [68Ga]DOTA-ANCP-PSMA

Aug. 6, 2020

Topline data from phase II/III registration study of pegloprastide

Aug. 5, 2020

First-in-human study of [124I]JS-001 PET/CT and PET/MR in patients with melanoma

Aug. 5, 2020

AC Immune describes enhanced alpha-synuclein PET tracers

Aug. 5, 2020

Gallium-68-labeled denosumab synthesized for PET imaging of tumor microenvironment

Aug. 5, 2020

French researchers disclose TfR1-targeting antibodies

Aug. 4, 2020

Clinical evaluation of [18F]EKZ-001 PET radiotracer to quantify HDAC6 brain expression

July 31, 2020

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...